CC Pharm | Nitroprusside

Sodium nitroprusside is an ultra-potent, direct-acting peripheral vasodilator characterized by rapid hemodynamic action and highly toxic metabolites. This 80/20 summary distills its essential clinical, pharmacological, and nursing guidelines: 1. Mechanism & Hemodynamic Effects Mechanism: Direct action on arterial and venous smooth muscle; myocardial contractility is unaffected. Hypertension: Reduces afterload and causes venous pooling, decreasing arteriolar resistance. Heart Failure: Improves left ventricular performance, increasing cardiac index, cardiac output, and stroke volume while slowing heart rate. 2. Dosing & Clinical Administration Onset & Duration: Rapid onset (1-2 mins); effects persist for 1-10 mins after discontinuation. Titration: Confirm drug effect for 5 minutes before titrating to a higher dose. Dosing (Adults): Hypertensive Emergency: Start 0.3-0.5 mcg/kg/min; titrate by 0.5 mcg/kg/min every 5 mins. Max: 10 mcg/kg/min for 10 mins. Acute Heart Failure: Start 0.1-0.3 mcg/kg/min. Max: 10 mcg/kg/min (doses >400 mcg/min have no added benefit). Mitral Regurgitation: Start 15 mcg/min, titrate every 2 mins to reduce mean arterial pressure by 10-20 mmHg. Preparation & Administration: Dilute 50 mg in 250–1000 mL of 5% Dextrose (D5W). Never give direct IV injection. Solution is clear, colorless to red/brown; discard if blue, green, or bright red. Protect from light during administration with an opaque sleeve. Do not run other drugs in the same solution. 3. Boxed Warning: Cyanide & Thiocyanate Toxicity Cyanide Toxicity: Metabolism produces dose-related cyanide. Doses >2 mcg/kg/min exceed normal clearance. Buffering is exceeded in <1 hour at the max 10 mcg/kg/min rate. Action: Discontinue and consider sodium nitrite and sodium thiosulfate. Thiocyanate Toxicity: Cyanide converts to thiocyanate via mitochondrial rhodanase (renal half-life: 3 days). Life-threatening at 200 mg/L. Monitor plasma levels if cumulative doses exceed 7 mg/kg/day. Organ Impairment Risk: Hepatic disease: High susceptibility to cyanide toxicity. Renal Impairment: eGFR <30: limit mean infusion to <3 mcg/kg/min (Anuria: limit to 1 mcg/kg/min). 4. Nursing Interventions Monitoring: Mandatory continuous blood pressure monitoring, preferably via an intraarterial pressure sensor. Monitor urine output in heart failure. Safety: Use a volumetric infusion pump. Watch for hypotension, methemoglobinemia, bradycardia, or metabolic acidosis.